TrialThe American journal of drug and alcohol abuse2025

Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone.

Azizi Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.